Catalyst Pharmaceutical Partners shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Catalyst Pharmaceutical Partners by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $17M | 1.1M | 15.94 |
| 2023-12-31 | $16M | 956k | 16.81 |
| 2023-09-30 | $11M | 921k | 11.69 |
| 2023-06-30 | $12M | 863k | 13.44 |
| 2023-03-31 | $20M | 1.2M | 16.58 |
| 2022-12-31 | $23M | 1.2M | 18.60 |
| 2022-09-30 | $16M | 1.2M | 12.83 |
| 2022-06-30 | $8.3M | 1.2M | 7.01 |
| 2022-03-31 | $6.9M | 831k | 8.29 |
| 2021-12-31 | $5.6M | 820k | 6.77 |
| 2021-09-30 | $4.2M | 801k | 5.30 |
| 2021-06-30 | $4.6M | 799k | 5.75 |
| 2021-03-31 | $4.5M | 970k | 4.61 |
| 2020-12-31 | $3.3M | 995k | 3.34 |
| 2020-09-30 | $2.7M | 900k | 2.97 |
| 2020-06-30 | $4.2M | 906k | 4.62 |
| 2020-03-31 | $3.3M | 865k | 3.85 |
| 2019-12-31 | $3.0M | 810k | 3.75 |
| 2019-09-30 | $3.0M | 571k | 5.31 |
| 2019-06-30 | $869k | 226k | 3.84 |
| 2019-03-31 | $1.2M | 226k | 5.10 |
| 2018-12-31 | $400k | 208k | 1.92 |
| 2018-09-30 | $788k | 208k | 3.78 |
| 2018-06-30 | $650k | 208k | 3.12 |
| 2018-03-31 | $442k | 185k | 2.39 |
| 2017-12-31 | $581k | 149k | 3.91 |
| 2017-09-30 | $304k | 121k | 2.52 |
| 2017-06-30 | $333k | 121k | 2.76 |
| 2016-03-31 | $126k | 107k | 1.17 |
| 2015-12-31 | $263k | 107k | 2.45 |
| 2015-09-30 | $323k | 107k | 3.01 |
| 2015-06-30 | $444k | 107k | 4.14 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners